TrialCancer2018
Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma.
Ajai Chari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papertrialcites it